The success rate of the treatment in each arm as per the five-point IGA scale by week 12 is the trial’s primary endpoint. Kintor Pharmaceutical has concluded subject enrolment in its Phase II clinical trial in China analysing KX-826 (pyrilutamide) to treat…
FDA grants IND clearance for Phase I trials of Phanes’ cancer antibody
PT217 has previously received orphan drug designation from the FDA to treat SCLC. The US Food and Drug Administration (FDA) has granted clearance for Phanes Therapeutics’ Investigational New Drug (IND) application to begin Phase I clinical trials of antibody PT217…
Alterity Therapeutics obtains approval in Australia to begin MSA therapy
The trial will assess the efficacy and safety of ATH434 in early-stage Multiple System Atrophy patients. Alterity Therapeutics has received the St. Vincent’s Hospital Melbourne Human Research Ethics Committee’s (HREC) approval to begin the Phase II clinical trial of ATH434…
ObvioHealth launches new patient engagement suite for clinical trials
The products and services are deployed through the ObvioGo platform and app and increase compliance and retention in clinical trials. Deployed through ObvioHealth’s ObvioGo platform and app, these products and services increase compliance and retention in clinical trials and deliver…
FDA grants funds for clinical trials in rare diseases
A contract will study if the physical evaluation of ALS patients in the at-home setting can reduce burden on patients. The US Food and Drug Administration (FDA) has awarded 19 new grants and two contracts worth over $38m to support…
GSK and Tempus partner to boost clinical trial design
The partnership is said to have a three-year financial commitment for which GSK has made an initial payment of $70m. GSK has signed a three-year partnership agreement with Tempus to enhance clinical trial design, expedite subject enrolment and detect drug targets. Under the…
UK sees decline in clinical trials over last five years, ABPI finds
According to the ABPI report, some pharmaceutical firms are forced to conduct their trials in other countries. The Association of the British Pharmaceutical Industry (ABPI) has reported that the number of industry clinical trials started in the UK each year dropped by…
Walmart follows CVS, Walgreens into clinical trial sector
Walmart is the latest US retail pharmacy giant to announce its intention of disrupting the clinical trials category, with the launch of a new institute that pledges to increase and diversify community access to healthcare research. The Walmart Healthcare Research…
Digital therapeutic cuts IPF-related anxiety by half in pilot study
Swedish digital health company Alex Therapeutics has reported encouraging results in a trial of a digital therapeutic (DTx) for anxiety in patients with the respiratory disease idiopathic pulmonary fibrosis (IPF). The cognitive behavioural therapy-based DTx – called Almee (formerly VP04)…
Dana-Farber’s computer platform makes patient matching process easier
MatchMiner can be used by a clinician or an oncologist to look up trial options for a patient. Dana-Farber Cancer Institute designers have reported in a new study that its computer platform makes the patient matching process easier, as well…
